163 related articles for article (PubMed ID: 26066583)
1. A UPLC-MS-MS method for the simultaneous quantification of first-line antituberculars in plasma and in PBMCs.
Baietto L; Calcagno A; Motta I; Baruffi K; Poretti V; Di Perri G; Bonora S; D'Avolio A
J Antimicrob Chemother; 2015 Sep; 70(9):2572-5. PubMed ID: 26066583
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous quantification of isoniazid, rifampicin, ethambutol and pyrazinamide by liquid chromatography/tandem mass spectrometry.
Prahl JB; Lundqvist M; Bahl JM; Johansen IS; Andersen ÅB; Frimodt-Møller N; Cohen AS
APMIS; 2016 Nov; 124(11):1004-1015. PubMed ID: 27546025
[TBL] [Abstract][Full Text] [Related]
3. Oral bioavailability of rifampicin, isoniazid, ethambutol, and pyrazinamide in a 4-drug fixed-dose combination compared with the separate formulations in healthy Chinese male volunteers.
Xu J; Jin H; Zhu H; Zheng M; Wang B; Liu C; Chen M; Zhou L; Zhao W; Fu L; Lu Y
Clin Ther; 2013 Feb; 35(2):161-8. PubMed ID: 23410999
[TBL] [Abstract][Full Text] [Related]
4. Standardization and validation of a novel UPLC-MS/MS method to quantify first line anti-tuberculosis drugs in plasma and dried blood spots.
Herrera-Pérez IG; Rodríguez-Báez AS; Ortiz-Álvarez A; Velarde-Salcedo R; Arriaga-García FJ; Rodríguez-Pinal CJ; Romano-Moreno S; Milán-Segovia RDC; Medellín-Garibay SE
J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Aug; 1228():123801. PubMed ID: 37453389
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of a hydrophilic interaction liquid chromatography-tandem mass spectrometry method for the simultaneous determination of five first-line antituberculosis drugs in plasma.
Zhou Z; Wu X; Wei Q; Liu Y; Liu P; Ma A; Zou F
Anal Bioanal Chem; 2013 Jul; 405(19):6323-35. PubMed ID: 23719934
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of 2 h plasma concentrations of first-line anti-tuberculosis drugs: a prospective observational study.
Prahl JB; Johansen IS; Cohen AS; Frimodt-Møller N; Andersen ÅB
J Antimicrob Chemother; 2014 Oct; 69(10):2841-7. PubMed ID: 25140577
[TBL] [Abstract][Full Text] [Related]
7. Systemic exposure to rifampicin in patients with tuberculosis and advanced HIV disease during highly active antiretroviral therapy in Burkina Faso.
Saleri N; Dembélé SM; Villani P; Carvalho AC; Cusato M; Bonkoungou V; Nacanabo R; Kouanda S; Comelli M; Regazzi M; Matteelli A
J Antimicrob Chemother; 2012 Feb; 67(2):469-72. PubMed ID: 22028201
[TBL] [Abstract][Full Text] [Related]
8. Rapid and sensitive method for simultaneous determination of first-line anti-tuberculosis drugs in human plasma by HPLC-MS/MS: Application to therapeutic drug monitoring.
Gao S; Wang Z; Xie X; You C; Yang Y; Xi Y; Chen W
Tuberculosis (Edinb); 2018 Mar; 109():28-34. PubMed ID: 29559118
[TBL] [Abstract][Full Text] [Related]
9. A rapid and sensitive HPLC-MS method for the detection of plasma and cellular rifampicin.
Hartkoorn RC; Khoo S; Back DJ; Tjia JF; Waitt CJ; Chaponda M; Davies G; Ardrey A; Ashleigh S; Ward SA
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 857(1):76-82. PubMed ID: 17643357
[TBL] [Abstract][Full Text] [Related]
10. Distribution of plasma concentrations of first-line anti-TB drugs and individual MICs: a prospective cohort study in a low endemic setting.
Niward K; Davies Forsman L; Bruchfeld J; Chryssanthou E; Carlström O; Alomari T; Carlsson B; Pohanka A; Mansjö M; Jonsson Nordvall M; Johansson AG; Eliasson E; Werngren J; Paues J; Simonsson USH; Schön T
J Antimicrob Chemother; 2018 Oct; 73(10):2838-2845. PubMed ID: 30124844
[TBL] [Abstract][Full Text] [Related]
11. Method for simultaneous analysis of nine second-line anti-tuberculosis drugs using UPLC-MS/MS.
Han M; Jun SH; Lee JH; Park KU; Song J; Song SH
J Antimicrob Chemother; 2013 Sep; 68(9):2066-73. PubMed ID: 23657802
[TBL] [Abstract][Full Text] [Related]
12. Rapid and highly sensitive quantification of the anti-tuberculosis agents isoniazid, ethambutol, pyrazinamide, rifampicin and rifabutin in human plasma by UPLC-MS/MS.
Wu L; Ye Z; Liu H; Guo H; Lin J; Zheng L; Chu N; Liu X
J Pharm Biomed Anal; 2020 Feb; 180():113076. PubMed ID: 31896523
[TBL] [Abstract][Full Text] [Related]
13. LC-MS/MS method for simultaneous quantification of the first-line anti-tuberculosis drugs and six primary metabolites in patient plasma: Implications for therapeutic drug monitoring.
Kivrane A; Grinberga S; Sevostjanovs E; Igumnova V; Pole I; Viksna A; Bandere D; Krams A; Cirule A; Pugovics O; Ranka R
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Nov; 1185():122986. PubMed ID: 34688197
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination of first-line anti-tuberculosis drugs and their major metabolic ratios by liquid chromatography/tandem mass spectrometry.
Song SH; Jun SH; Park KU; Yoon Y; Lee JH; Kim JQ; Song J
Rapid Commun Mass Spectrom; 2007; 21(7):1331-8. PubMed ID: 17340570
[TBL] [Abstract][Full Text] [Related]
15. Isoniazid, rifampicin and pyrazinamide plasma concentrations 2 and 6 h post dose in patients with pulmonary tuberculosis.
Fahimi F; Tabarsi P; Kobarfard F; Bozorg BD; Goodarzi A; Dastan F; Shahsavari N; Emami S; Habibi M; Salamzadeh J
Int J Tuberc Lung Dis; 2013 Dec; 17(12):1602-6. PubMed ID: 24200276
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.
Ribera E; Azuaje C; Lopez RM; Domingo P; Curran A; Feijoo M; Pou L; Sánchez P; Sambeat MA; Colomer J; Lopez-Colomes JL; Crespo M; Falcó V; Ocaña I; Pahissa A
J Antimicrob Chemother; 2007 Apr; 59(4):690-7. PubMed ID: 17307771
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of anti-TB drugs in Malawian children: reconsidering the role of ethambutol.
Mlotha R; Waterhouse D; Dzinjalamala F; Ardrey A; Molyneux E; Davies GR; Ward S
J Antimicrob Chemother; 2015; 70(6):1798-803. PubMed ID: 25759035
[TBL] [Abstract][Full Text] [Related]
18. Cure of tuberculosis despite serum concentrations of antituberculosis drugs below published reference ranges.
Meloni M; Corti N; Müller D; Henning L; Gutteck U; von Braun A; Weber R; Fehr J
Swiss Med Wkly; 2015; 145():w14223. PubMed ID: 26700218
[TBL] [Abstract][Full Text] [Related]
19. LC-QToF-MS method for quantification of ethambutol, isoniazid, pyrazinamide and rifampicin in human plasma and its application.
Fachi MM; Vilhena RO; Boger B; Domingos EL; Dos Santos JMMF; Junkert AM; de Fátima Cobre A; Momade DRO; Beraldi-Magalhães F; de Liz MV; Cordeiro-Santos M; Pontarolo R
Biomed Chromatogr; 2020 May; 34(5):e4812. PubMed ID: 32068899
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of anti-tuberculosis drugs in Venezuelan children younger than 16 years of age: supportive evidence for the implementation of revised WHO dosing recommendations.
Verhagen LM; López D; Hermans PW; Warris A; de Groot R; García JF; de Waard JH; Aarnoutse RE
Trop Med Int Health; 2012 Dec; 17(12):1449-56. PubMed ID: 23094704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
